Health Dictionary AI Health Chat Find an Online Doctor

Dyspepsia pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahad Hasan, M.D.[2] Ajay Gade MD[3]]

Overview

Overview

Functional dyspepsia is now classified as a disorder of gut-brain interaction, affecting approximately 7% of the community, and is diagnosed by the presence of bothersome epigastric pain or burning, early satiation, and/or postprandial fullness for longer than 8 weeks in the absence of an identifiable organic cause.[1] The symptoms of functional dyspepsia are directly caused by two major pathophysiological abnormalities in gastric motility and visceral sensitivity, with recent evidence adding impaired gastric accommodation and low-grade duodenal mucosal inflammation, including duodenal eosinophilia and increased mast cell density, as key contributory mechanisms.[2] These mechanisms occur in patients who have acquired excessive responsiveness to stress as a result of the environment during early life, genetic abnormalities, residual inflammation after gastrointestinal infections, or other causes. The process may be modified by factors including psychophysiological abnormalities, abnormal secretion of gastric acid, Helicobacter pylori infection, impaired duodenal mucosal barrier integrity, diet, and lifestyle.

Pathophysiology

Pathophysiology

The pathophysiology of dyspepsia is as follows:[3][4][5][6][7][8][9][1][2]

Physiology of digestion

Pathophysiology of functional dyspepsia

Gross Pathology

Gross Pathology

  • Gastric ulcers are most often localized on the lesser curvature of the stomach
  • Duodenal ulcers are more located at bulb of duodenum
  • Characteristic findings of a peptic ulcer on gross pathology include:
    • Round to oval
    • Two to four cm diameter
    • Smooth base with perpendicular borders.
    • Parietal scarring with radial folds may be evident in the surrounding mucosa
Microscopic Pathology

Microscopic Pathology

  • A peptic ulcer is a mucosal defect produced by acid-pepsin aggression which penetrates the muscularis mucosae and muscularis propria
  • There is increased plasma cells, neutrophilic infiltrate, villous blunting
  • The surface epithelium usually shows mucous cell (pseudopyloric) metaplasia
  • During the active phase, the base of the ulcer shows 4 zones:
    • Inflammatory exudate: polymorphonuclear infiltration which along with bacterial products stimulate the production of IL-8 and tumor necrosis factor alpha (TNF-α) and IL-1 released by macrophages in response to bacterial lipopolysaccharide
    • Fibrinoid necrosis
    • Granulation tissue
    • Fibrous tissue. The fibrous base of the ulcer may contain vessels with thickened wall or with thrombosis[14]
  • In functional dyspepsia specifically, routine histology is typically unremarkable on standard staining, but quantitative studies using specialized immunohistochemistry demonstrate increased duodenal eosinophil and mast cell counts per high-power field compared with controls, supporting a distinct microscopic correlate of the “leaky gut” model described above.[11][15]
References

References

  1. 1.0 1.1 1.2 Black CJ, Paine PA, Agrawal A, Alqahtani A, Anand B, Byrne P, Clark CE, Corr A, Doherty G, Excell L, Ford AC, Kemp K, Nwokolo C, Owen L, Paranandi B, Ritchie N, Robertson E, Whorwell P, Wright S, Hasan B (2022). “British Society of Gastroenterology guidelines on the management of functional dyspepsia”. Gut. 71 (9): 1697–1723. doi:10.1136/gutjnl-2022-327737. PMID 35798375 Check |pmid= value (help).
  2. 2.0 2.1 2.2 2.3 2.4 Ford AC, Mahadeva S, Carbone MF, Lacy BE, Talley NJ (2020). “Functional dyspepsia”. Lancet. 396 (10263): 1689–1702. doi:10.1016/S0140-6736(20)30469-4. PMID 33049222 Check |pmid= value (help).
  3. 3.0 3.1 Talley NJ, Ford AC (2015). “Functional Dyspepsia”. N. Engl. J. Med. 373 (19): 1853–63. doi:10.1056/NEJMra1501505. PMID 26535514.
  4. Napthali K, Koloski N, Walker MM, Talley NJ (2016). “Women and functional dyspepsia”. Womens Health (Lond). 12 (2): 241–50. doi:10.2217/whe.15.88. PMC 5375052. PMID 26901578.
  5. Talley NJ (2016). “Functional dyspepsia: new insights into pathogenesis and therapy”. Korean J. Intern. Med. 31 (3): 444–56. doi:10.3904/kjim.2016.091. PMC 4855108. PMID 27048251.
  6. Ganesh M, Nurko S (2014). “Functional dyspepsia in children”. Pediatr Ann. 43 (4): e101–5. doi:10.3928/00904481-20140325-12. PMID 24716560.
  7. 7.0 7.1 Fock KM (2011). “Functional dyspepsia, H. pylori and post infectious FD”. J. Gastroenterol. Hepatol. 26 Suppl 3: 39–41. doi:10.1111/j.1440-1746.2011.06649.x. PMID 21443707.
  8. Oustamanolakis P, Tack J (2012). “Dyspepsia: organic versus functional”. J. Clin. Gastroenterol. 46 (3): 175–90. doi:10.1097/MCG.0b013e318241b335. PMID 22327302.
  9. 9.0 9.1 Kindt S, Dubois D, Van Oudenhove L, Caenepeel P, Arts J, Bisschops R, Tack J (2009). “Relationship between symptom pattern, assessed by the PAGI-SYM questionnaire, and gastric sensorimotor dysfunction in functional dyspepsia”. Neurogastroenterol. Motil. 21 (11): 1183–e105. doi:10.1111/j.1365-2982.2009.01374.x. PMID 19663903.
  10. Pasricha PJ, Grover M, Yates KP, Abell TL, Bernard CE, Koch KL; et al. (2021). “Functional Dyspepsia and Gastroparesis in Tertiary Care are Interchangeable Syndromes With Common Clinical and Pathologic Features”. Gastroenterology. 160 (6): 2006–2017. doi:10.1053/j.gastro.2021.01.230. PMID 33548234 Check |pmid= value (help).
  11. 11.0 11.1 Vanheel H, Vicario M, Vanuytsel T, Van Oudenhove L, Martinez C, Keita ÅV, Pardon N, Santos J, Söderholm JD, Tack J, Farré R (2014). “Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia”. Gut. 63 (2): 262–71. doi:10.1136/gutjnl-2012-303857. PMID 23474421.
  12. Walker MM, Talley NJ, Prabhakar M, Pennaneac’h CJ, Aro P, Ronkainen J, Storskrubb T, Harmsen WS, Zinsmeister AR, Agréus L (2009). “Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia”. Aliment. Pharmacol. Ther. 29 (7): 765–73. doi:10.1111/j.1365-2036.2009.03937.x. PMID 19183150.
  13. Miwa H (2012). “Why dyspepsia can occur without organic disease: pathogenesis and management of functional dyspepsia”. J Gastroenterol. doi:10.1007/s00535-012-0625-9. PMID 22766746. Unknown parameter |month= ignored (help)
  14. “ATLAS OF PATHOLOGY”. Retrieved 2007-08-26.
  15. Walker MM, Talley NJ, Prabhakar M, Pennaneac’h CJ, Aro P, Ronkainen J, Storskrubb T, Harmsen WS, Zinsmeister AR, Agreus L. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther. 2009 Apr 1;29(7):765-73. doi: 10.1111/j.1365-2036.2009.03937.x. Epub 2009 Jan 17. PMID: 19183150

Template:WS Template:WH

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH